Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMGN vs GSK✓SelectedUSD · GSKAMGN vs GSK performance historyLatest closeAs of-0.72%11/16
Stock and ETF performance explorer

AMGN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+160.8%
GSK return
+46.9%
Excess return
+113.9%
Maximum drawdown
-24.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-0.1%-0.6%-0.7%
7D-0.6%-1.3%+0.7%-0.1%
30D+6.9%+2.7%+4.2%+5.6%
3M+12.0%+2.7%+9.3%+10.7%
6M+42.5%+3.3%+39.2%+40.5%
YTD+44.1%+6.5%+37.7%+40.8%
1Y+41.1%+10.7%+30.4%+35.9%
3Y+86.6%+64.4%+22.2%+55.6%
5Y+160.8%+46.7%+114.1%+112.5%
All+160.8%+46.9%+113.9%+112.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling